Stevenage, United Kingdom

Mike Trower

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Herts, GB (2017 - 2018)
  • Stevenage, GB (2019 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mike Trower: Innovator in Pharmaceutical Formulations

Introduction

Mike Trower is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work focuses on innovative treatments that address various medical conditions, showcasing his dedication to improving healthcare.

Latest Patents

Among his latest patents is a method for treating symptoms of menopause. This invention relates to novel pharmaceutical formulations containing complex chemical compounds designed to alleviate menopausal symptoms. Another significant patent involves the use of neurokinin-1 receptor antagonists as a treatment for pulmonary fibrosis conditions, particularly those induced by mechanical injury to the lungs. This innovative approach aims to provide relief for patients suffering from cough-related issues associated with pulmonary fibrosis.

Career Highlights

Throughout his career, Mike Trower has worked with various companies, including Kandy Therapeutics Limited and Nerre Therapeutics Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical therapies.

Collaborations

Mike has collaborated with several professionals in the field, including Mary Kerr and Monica Lazaro. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Mike Trower is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact medical treatments. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…